Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Becton Dickinson Medical (Singapore)
EIR
•Becton Dickinson Medical (Singapore)•October 25, 2018

Becton Dickinson Medical (Singapore) – FDA EIR, Oct 25, 2018

Record Details

The FDA conducted a comprehensive Level 2 Quality System Inspection Technique (QSIT) inspection of Becton Dickinson Medical (Singapore), Pte. Ltd. from October 22 to October 25, 2018. The inspection was part of routine surveillance under the Center for Devices and Radiological Health's (CDRH) 2019 work plan, guided by Compliance Programs 7382.845 for medical device manufacturers.

Becton Dickinson Medical (Singapore) manufactures Class 2 luer lock syringes and safety needles. The inspection focused on four major medical device subsystems: Management Controls, Design Controls, Corrective and Preventive Actions (CAPA), and Production and Process Controls (P&PC). Additional areas reviewed included validation, sterilization, and Purchasing Management/Supplier Controls. The inspection also evaluated the Records, Documents, and Change Controls subsystem.

No deficiencies were identified during the previous inspection in September 2015, which was also a Level 2 surveillance inspection. The 2015 inspection did not cover Design Controls and had limited coverage of P&PC and CAPA. The current inspection aimed to address these areas comprehensively.

The inspection did not result in any citations on Form FDA 483, indicating no significant violations or issues were found. The firm is expected to maintain compliance with FDA regulations and ensure ongoing adherence to quality management practices. The inspection findings will support the FDA's continued oversight and assurance of the safety and effectiveness of the medical devices produced by Becton Dickinson Medical (Singapore).

Company
Becton Dickinson Medical (Singapore)
Inspection date
October 25, 2018
Product type
Device
Office
Office of Regulatory Affairs
Person
  • David H. Smith
View Company Profile

ID · afe7ae7a-8be5-4a7b-994c-26298dddbef2

Violation Codes1
21 CFR 803.19

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Becton Dickinson Medical (Singapore)
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.